AHFS Drug Information
iOS Universel / Medecine
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content.
AHFS Drug Information® 2024: AHFS® Drug Information™ - Doody's Core Title - is your comprehensive, interactive treatment and drug therapy solution - complete with therapeutic guidelines and off-label uses.
Named a Doody's Core Title in 2023!
AHFS Drug Information® 2024 contains the most dependable drug information available?all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
Updates in the new edition:
* Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
* Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
* Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
* Expanded content on new and emerging gene therapies
* Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines Expanded content on off-label uses and long-term clinical data
* MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
* New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications
* Searchable and scalable database where you can search the index or perform a full-text search
* Ability to create user-specific favorites and add notes
* AHFS class for each drug based on the AHFS® Pharmacologic-Therapeutic Classification
No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.
Content licensed from printed ISBN 10: 1585287210
Content licensed from printed ISBN 13: 9781585287215
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $99.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): Gerald K. McEvoy, Pharm.D, Editor-in-Chief: Elaine K. Snow
Publisher: American Society of Health-System Pharmacists
Quoi de neuf dans la dernière version ?
We want you to get notified about exclusive offers, promotions, and discounts. This updates does this directly through in-app notifications.
Experience the full power of having AHFS Drug Information® 2024 for healthcare professionals including pharmacist a mobile app,
The latest version includes:
- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
- Expanded content on new and emerging gene therapies
- Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines
- Expanded content on off-label uses and long-term clinical data
- MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
- New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications
Also check out these feature releases in the mobile app:
- Read alerts under MedBeats relevant to your specialty
- Use "Spotlight Search" from Home screen
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
